Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

NCT03713944 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Extreme toxicity, thromboembolic events

Conditions

NSCLC Stage IV
NSCLC, Recurrent

Interventions

DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Atezolizumab
DRUG: Bevacizumab

Sponsor

Nasser Hanna

Collaborators

[object Object]